USA Today: Price increases on insulin force PBMs to shift coverage
December 24, 2016
As drugmakers raise the price of insulin drugs, pharmacy benefit managers are opting to cover less expensive, clinically effective, options...
Drug Benefit Solutions is an educational platform explaining how pharmacy benefit managers (PBMs) reduce costs and improve quality on prescription drug benefits for consumers, employers, unions, and government programs.
Drug Benefit Solutions is a project of the Pharmaceutical Care Management Association (PCMA).
Recent News
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
- Waste
RealClearHealth: PCMA President Merritt: PBMs protect consumers, employers from high drug prices
December 09, 2016
Some pharma industry executives have tried to blame pharmacy benefit managers for high drug prices, claiming that PBMs somehow force...
Reuters: PBM-negotiated discounts reducing global growth in drug spending
December 06, 2016
The US is expected to spend, at an annual rate, between 4% to 7% on prescription drugs when accounting for...
Forbes: Private Prescription Drug Negotiation: The Key To Successful Public Policy
November 29, 2016
The rollout of new drugs like Sovaldi, the pricing revelations at Turing Pharmaceuticals, and the Epipen episode have fed both...
The Washington Post: PBM negotiations on insulin products generating discounts for consumers
November 18, 2016
Pharmacy benefit managers have driven discounts on insulin drugs for consumers by creating lists of covered drugs in which some...
PCMA President Mark Merritt Outlines How PBMs Reduce Prescription Drug Costs
November 01, 2016
Typically, pharmacy benefit managers (PBMs) reduce drug-benefit costs up to 30 percent for more than 266 million Americans enrolled in...
PBMs: Part of the Solution to High Drug Prices
October 17, 2016
Recently, three changes in the health care terrain collided to raise new concerns over rising drug prices: the advent of...
The Hill: PCMA President Op-Ed on Rx Prices: PBMs: Part of the Solution to High Drug Prices
October 17, 2016
The competition-based PBM approach has been highly successful, yielding broad access to prescription drugs and 90% consumer satisfaction rates....
The New York Times: Drug Coupons: Helping a Few at the Expense of Everyone
October 12, 2016
A research team from Harvard, Northwestern and the University of California, Los Angeles, looked at brand-name drugs that also had...
PCMA President Mark Merritt Outlines How PBMs Reduce Prescription Drug Costs
September 30, 2016
In this era of high drug prices and expensive specialty medicines, the role of pharmacy benefit managers has never been...
Employers Prefer Private-Sector Solutions on High Drug Costs, PCMA Survey Shows
September 16, 2016
It’s a forgone conclusion that most of the consumer public doesn’t like pharma companies’ pricing policies, as headlines were grabbed...
Forbes: Mylan’s EpiPen Price ‘Cut’ An Outdated Drug Industry PR Move
August 28, 2016
It’s not surprising that EpiPen maker Mylan would defend its 400% price increase with the line that it’s okay because...